These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
975 related items for PubMed ID: 12122531
1. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Hennersdorf MG, Perings SM, Zühlke C, Heidland UE, Perings C, Heintzen MP, Strauer BE. Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531 [Abstract] [Full Text] [Related]
2. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Bernard EO, Schmid ER, Schmidlin D, Scharf C, Candinas R, Germann R. Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468 [Abstract] [Full Text] [Related]
3. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. Hongo RH, Themistoclakis S, Raviele A, Bonso A, Rossillo A, Glatter KA, Yang Y, Scheinman MM. J Am Coll Cardiol; 2004 Aug 18; 44(4):864-8. PubMed ID: 15312873 [Abstract] [Full Text] [Related]
4. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS. J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872 [Abstract] [Full Text] [Related]
5. The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm. Sideris S, Bonios M, Melexopoulou C, Exarchos P, Tsatiris K, Kogias J. Cardiology; 2007 Aug 18; 107(4):399-401. PubMed ID: 17284902 [Abstract] [Full Text] [Related]
6. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Kafkas NV, Patsilinakos SP, Mertzanos GA, Papageorgiou KI, Chaveles JI, Dagadaki OK, Kelesidis KM. Int J Cardiol; 2007 Jun 12; 118(3):321-5. PubMed ID: 17049640 [Abstract] [Full Text] [Related]
7. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone. Fragakis N, Papadopoulos N, Papanastasiou S, Kozirakis M, Maligkos G, Tsaritsaniotis E, Katsaris G. Pacing Clin Electrophysiol; 2005 Sep 12; 28(9):954-61. PubMed ID: 16176535 [Abstract] [Full Text] [Related]
8. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation. Nair M, George LK, Koshy SK. J Am Board Fam Med; 2011 Sep 12; 24(1):86-92. PubMed ID: 21209348 [Abstract] [Full Text] [Related]
9. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Glatter K, Yang Y, Chatterjee K, Modin G, Cheng J, Kayser S, Scheinman MM. Circulation; 2001 Jan 16; 103(2):253-7. PubMed ID: 11208685 [Abstract] [Full Text] [Related]
10. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter. Steinwender C, Hönig S, Kypta A, Kammler J, Schmitt B, Leisch F, Hofmann R. Int J Cardiol; 2010 Jun 11; 141(3):260-5. PubMed ID: 19136164 [Abstract] [Full Text] [Related]
11. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B, Straumann E, Bertel O. Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188 [Abstract] [Full Text] [Related]
12. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent. Patsilinakos S, Christou A, Kafkas N, Nikolaou N, Antonatos D, Katsanos S, Spanodimos S, Babalis D. Am J Cardiol; 2010 Sep 01; 106(5):673-6. PubMed ID: 20723644 [Abstract] [Full Text] [Related]
13. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study]. Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM. Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393 [Abstract] [Full Text] [Related]
14. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine]. Trappe HJ, Pfitzner P. Med Klin (Munich); 1996 Oct 15; 91(10):617-25. PubMed ID: 9019638 [Abstract] [Full Text] [Related]
15. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Zarkin GA, Bala MV, Calingaert B, VanderLugt JT. Am J Manag Care; 1997 Sep 15; 3(9):1387-94. PubMed ID: 10178487 [Abstract] [Full Text] [Related]
16. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study. Cotter G, Blatt A, Kaluski E, Metzkor-Cotter E, Koren M, Litinski I, Simantov R, Moshkovitz Y, Zaidenstein R, Peleg E, Vered Z, Golik A. Eur Heart J; 1999 Dec 15; 20(24):1833-42. PubMed ID: 10581142 [Abstract] [Full Text] [Related]
18. The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Hoyer AW, Balaji S. Pacing Clin Electrophysiol; 2007 Aug 15; 30(8):1003-8. PubMed ID: 17669084 [Abstract] [Full Text] [Related]
19. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter. Tercius AJ, Kluger J, Coleman CI, White CM. Pacing Clin Electrophysiol; 2007 Nov 15; 30(11):1331-5. PubMed ID: 17976094 [Abstract] [Full Text] [Related]
20. Arrhythmias in the intensive care patient. Trappe HJ, Brandts B, Weismueller P. Curr Opin Crit Care; 2003 Oct 15; 9(5):345-55. PubMed ID: 14508146 [Abstract] [Full Text] [Related] Page: [Next] [New Search]